True and Missed Interval Cancer in Organized Mammographic Screening: A Retrospective Review Study of Diagnostic and Prior Screening Mammograms

Hovda, Tone; Hoff, Solveig Roth; Larsen, Marthe; Romundstad, Linda; Sahlberg, Kristine Kleivi; Hofvind, Solveig

doi:10.1016/j.acra.2021.03.022

Cited by 29 publications

(23 citation statements)

References 170 publications

(292 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Informed reviews of prior screening and diagnostic mammograms performed by groups of radiologists have classified about 25% of the screen-detected and interval cancers as missed (6,7). Also, it has been reported that 20% of screen-detected cancers were recommended for recall by one of two radiologists in independent double reading (8).…”

Section: Introductionmentioning

confidence: 99%

Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program

Larsen¹,

Aglen²,

Lee³

et al. 2022

Radiology

Self Cite

View full text Add to dashboard Cite

The performance of the artificial intelligence system was promising for breast cancer detection in a large population-based mammography screening program. Key Results:• In this retrospective study of 122 969 examinations, mammograms were evaluated with an artificial intelligence (AI) system which predicts the risk of cancer on a scale from 1 (lowest risk) to 10 (highest risk). • A total of 87.6% (653 of 752) of screen-detected and 44.9% (92 of 205) of interval cancers had the highest AI score of 10; 0.7% (five of 752) screen-detected cancers had the lowest AI score of 1. • Interval cancers with high AI scores had favorable histopathological tumor characteristics compared to cancers with low AI scores; the opposite was observed for screen-detected cancers.

show abstract

Section: Introductionmentioning

confidence: 99%

Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program

Larsen¹,

Aglen²,

Lee³

et al. 2022

Radiology

Self Cite

View full text Add to dashboard Cite

show abstract

“…Hence, interval cancer rates can only be determined when routine screening is in place. These tumors could be true interval cancers that arise due to rapid tumor growth [ 128 ] or due to false negatives, which are cancers that were present on the mammograms but missed by the assessing professional [ 33 ]. Therefore, the interval cancer rate is an indicator of the quality of radiology and the effectiveness of screening programs [ 33 ].…”

Section: Findings and Interpretationsmentioning

confidence: 99%

Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives

Lim

et al. 2022

Cancers

View full text Add to dashboard Cite

Close to half (45.4%) of the 2.3 million breast cancers (BC) diagnosed in 2020 were from Asia. While the burden of breast cancer has been examined at the level of broad geographic regions, literature on more in-depth coverage of the individual countries and subregions of the Asian continent is lacking. This narrative review examines the breast cancer burden in 47 Asian countries. Breast cancer screening guidelines and risk-based screening initiatives are discussed.

show abstract

“…Hence, interval cancer rates can only be determined when routine screening is in place. These tumors could be true interval cancers that arise due to rapid tumor growth [123] or due to false negatives, which are cancers that were present on the mammograms but missed by the assessing professional [33]. Therefore, the interval cancer rate is an indicator of the quality of radiology and the effectiveness of screening programs [33].…”

Section: Interval Cancers -Breast Cancers Not Detected By Screening M...mentioning

confidence: 99%

Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programmes, and Risk-based Screening Initiatives

Lim¹,

Lim²,

Ho³

et al. 2022

Preprint

View full text Add to dashboard Cite

Close to half (45.4%) of 2.3 million breast cancers (BC) diagnosed in 2020 were from Asia. While the burden of breast cancer has been examined on the level of broad geographic regions, literature on more in-depth coverage of the individual countries and subregions of the Asian continent is lacking. This review examines the breast cancer burden in 47 Asian countries. Breast cancer screening guidelines and risk-based screening initiatives are discussed.

show abstract

True and Missed Interval Cancer in Organized Mammographic Screening: A Retrospective Review Study of Diagnostic and Prior Screening Mammograms

Cited by 29 publications

References 170 publications

Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program

Artificial Intelligence Evaluation of 122 969 Mammography Examinations from a Population-based Screening Program

Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives

Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programmes, and Risk-based Screening Initiatives

Contact Info

Product

Resources

About